Sareum Holdings plc (SAR.L)
Discovers and develops drug treatments for cancer and autoimmune diseases.
22.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+29.4%
The outlook
Sareum Holdings trades at 22p with minimal intraday movement, sitting about two-thirds of the way up its 52-week range. A single analyst rates it a Strong Buy with an average price target implying roughly 89% upside from current levels. The stock shows mixed positioning relative to its moving averages, though the overall scoring leans notably bullish.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendMixed vs its moving averages
52-week range64% of the way from its 52-week low to high
Price targetAvg target +89% vs current price
Market cap
$30.5M
52-wk high
29.00
52-wk low
9.50
50-day avg
22.48
200-day avg
18.05
Trailing P/E
—